Cargando…
Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed comparing interventions with standard care and each other. The She...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565660/ https://www.ncbi.nlm.nih.gov/pubmed/31020392 http://dx.doi.org/10.1007/s00431-019-03374-z |
_version_ | 1783426692694409216 |
---|---|
author | Fibert, Philippa Peasgood, Tessa Relton, Clare |
author_facet | Fibert, Philippa Peasgood, Tessa Relton, Clare |
author_sort | Fibert, Philippa |
collection | PubMed |
description | Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed comparing interventions with standard care and each other. The Sheffield Treatments for ADHD Research (STAR) project used the Trials within Cohorts (TwiCs) approach. A cohort of children with ADHD was recruited and outcomes collected from carers and teachers. A random selection was offered treatment by homoeopaths (hom) or nutritional therapists (NT). Their outcomes (Conners Global ADHD Index) were compared with those not offered interventions. The feasibility of the methods and interventions was assessed. The TwiCs approach was feasible with modifications. 144 participants were recruited to the cohort, 83 offered treatment, 72 accepted, and 50 attended 1+ appointments. Results according to carers assessments at 6 months were as follows: t = 1.08, p = .28 (− 1.48, 4.81) SMD .425 (hom); t = 1.71, p = .09 (− .347, 5.89), SMD = .388 (NT). Teachers’ responses were too few and unstable. No serious treatment adverse events occurred. Conclusion: the STAR project demonstrated the feasibility of the TwiCs approach for testing interventions for children with ADHD. |
format | Online Article Text |
id | pubmed-6565660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-65656602019-06-28 Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology Fibert, Philippa Peasgood, Tessa Relton, Clare Eur J Pediatr Original Article Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed comparing interventions with standard care and each other. The Sheffield Treatments for ADHD Research (STAR) project used the Trials within Cohorts (TwiCs) approach. A cohort of children with ADHD was recruited and outcomes collected from carers and teachers. A random selection was offered treatment by homoeopaths (hom) or nutritional therapists (NT). Their outcomes (Conners Global ADHD Index) were compared with those not offered interventions. The feasibility of the methods and interventions was assessed. The TwiCs approach was feasible with modifications. 144 participants were recruited to the cohort, 83 offered treatment, 72 accepted, and 50 attended 1+ appointments. Results according to carers assessments at 6 months were as follows: t = 1.08, p = .28 (− 1.48, 4.81) SMD .425 (hom); t = 1.71, p = .09 (− .347, 5.89), SMD = .388 (NT). Teachers’ responses were too few and unstable. No serious treatment adverse events occurred. Conclusion: the STAR project demonstrated the feasibility of the TwiCs approach for testing interventions for children with ADHD. Springer Berlin Heidelberg 2019-04-24 2019 /pmc/articles/PMC6565660/ /pubmed/31020392 http://dx.doi.org/10.1007/s00431-019-03374-z Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Fibert, Philippa Peasgood, Tessa Relton, Clare Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology |
title | Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology |
title_full | Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology |
title_fullStr | Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology |
title_full_unstemmed | Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology |
title_short | Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology |
title_sort | rethinking adhd intervention trials: feasibility testing of two treatments and a methodology |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565660/ https://www.ncbi.nlm.nih.gov/pubmed/31020392 http://dx.doi.org/10.1007/s00431-019-03374-z |
work_keys_str_mv | AT fibertphilippa rethinkingadhdinterventiontrialsfeasibilitytestingoftwotreatmentsandamethodology AT peasgoodtessa rethinkingadhdinterventiontrialsfeasibilitytestingoftwotreatmentsandamethodology AT reltonclare rethinkingadhdinterventiontrialsfeasibilitytestingoftwotreatmentsandamethodology |